Celldex Therapeutics, Inc. Other Comprehensive Income (Loss), before Reclassifications, Net of Tax
Celldex Therapeutics, Inc. (CLDX) reported Other Comprehensive Income (Loss), before Reclassifications, Net of Tax of $124.00 thousand for the 3-month period ending 2015-09-30, per its 10-Q filed 2015-11-05.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax · last filed 2015-11-05
- Celldex Therapeutics, Inc. other comprehensive income (loss), before reclassifications, net of tax for the quarter ending 2015-09-30 was $124.00K.
- Celldex Therapeutics, Inc. other comprehensive income (loss), before reclassifications, net of tax for the quarter ending 2015-06-30 was -$180.00K, a 330.77% decline year-over-year.
- Celldex Therapeutics, Inc. other comprehensive income (loss), before reclassifications, net of tax for the quarter ending 2015-03-31 was $26.00K, a 1200.00% increase year-over-year.
- Celldex Therapeutics, Inc. other comprehensive income (loss), before reclassifications, net of tax for the quarter ending 2014-12-31 was -$34.00K.
- Celldex Therapeutics, Inc. other comprehensive income (loss), before reclassifications, net of tax for fiscal 2014 was -$78.00K.
- Celldex Therapeutics, Inc. other comprehensive income (loss), before reclassifications, net of tax for fiscal 2013 was -$77.00K.
| Period end | Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 3 month | Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 6 month | Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 9 month | Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 12 month |
|---|---|---|---|---|
| 2015-09-30 | $124.00K 10-Q · filed 2015-11-05 | -$56.00K derived: sum of 2 quarters · filed 2015-11-05 | -$30.00K 10-Q · filed 2015-11-05 | -$64.00K derived: sum of 4 quarters · filed 2015-11-05 |
| 2015-06-30 | -$180.00K 10-Q · filed 2015-08-10 | -$154.00K 10-Q · filed 2015-08-10 | -$188.00K derived: sum of 3 quarters · filed 2015-08-10 | -$312.00K derived: sum of 4 quarters · filed 2015-08-10 |
| 2015-03-31 | $26.00K 10-Q · filed 2015-04-29 | -$8.00K derived: sum of 2 quarters · filed 2015-04-29 | -$132.00K derived: sum of 3 quarters · filed 2015-04-29 | -$54.00K derived: sum of 4 quarters · filed 2015-04-29 |
| 2014-12-31 | -$34.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | -$158.00K derived: sum of 2 quarters · filed 2015-02-24 | -$80.00K derived: sum of 3 quarters · filed 2015-02-24 | -$78.00K 10-K · filed 2015-02-24 |
| 2014-09-30 | -$124.00K 10-Q · filed 2014-11-05 | -$46.00K derived: sum of 2 quarters · filed 2014-11-05 | -$44.00K 10-Q · filed 2014-11-05 | -$62.00K derived: sum of 4 quarters · filed 2015-04-29 |
| 2014-06-30 | $78.00K 10-Q · filed 2014-08-07 | $80.00K 10-Q · filed 2014-08-07 | $62.00K derived: sum of 3 quarters · filed 2015-04-29 | $200.00K derived: sum of 4 quarters · filed 2015-04-29 |
| 2014-03-31 | $2.00K 10-Q · filed 2015-04-29 | -$16.00K derived: sum of 2 quarters · filed 2015-04-29 | $122.00K derived: sum of 3 quarters · filed 2015-04-29 | |
| 2013-12-31 | -$18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $120.00K derived: sum of 2 quarters · filed 2015-02-24 | -$77.00K 10-K · filed 2015-02-24 | |
| 2013-09-30 | $138.00K 10-Q · filed 2013-11-08 | -$59.00K 10-Q · filed 2013-11-08 | ||
| 2013-03-31 | -$56.00K 10-Q · filed 2014-05-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |